Cancer Targeted Gene Therapy for Inhibition of Melanoma Lung Metastasis with eIF3i shRNA Loaded Liposomes
Authors:
- 25 November 2019
- journal article
- research article
- Published by American Chemical Society (ACS) in Molecular Pharmaceutics
- Vol. 17 (1) , 229-238
Abstract
Eukaryotic translation initiation factors 3i (eIF3i) is a proto-oncogene that is overexpressed in various tumors, reducing its expression by eIF3i shRNA is a promising strategy to inhibit tumor growth or metastasis. Tumor cell is the target of eIF3i shRNA so that tumor-site accumulation could be important for fulfilling its therapeutic effect. Thus, the iRGD modified liposome (R-LP) was rational synthesized to enhance the anti-tumor effect by active targeted delivery of eIF3i shRNA to B16F10 melanoma cells. R-LP encapsulating eIF3i shRNA gene (R-LP/sheIF3i) were prepared by a film dispersion method. The transfection experiment proves that R-LP could effectively transfect B16F10 cells. R-LP/sheIF3i notably restrained the migration, invasion and adhesion of melanoma cells in vitro. In a mouse model of lung metastasis, R-LP/sheIF3i administered by intravenous injection suppressed pulmonary metastasis of melanoma by dramatically downregulated eIF3i expression and subsequently inhibiting tumor neovascularization and tumor cells proliferation in vivo. Our results provide a basis for tumor cells targeting strategies to reduce the expression of eIF3i by RNAi in the treatment of tumor metastasis.Keywords
Funding Information
- Ministry of Science and Technology of the People's Republic of China (2018ZX09201018-024)
- National Natural Science Foundation of China (81872821)
This publication has 41 references indexed in Scilit:
- Delivery of Soluble VEGF Receptor 1 (sFlt1) by Gene Electrotransfer as a New Antiangiogenic Cancer TherapyMolecular Pharmaceutics, 2011
- Bioreducible poly (β-amino esters)/shRNA complex nanoparticles for efficient RNA deliveryJournal of Controlled Release, 2011
- Prognostic factors for survival in melanoma patients with brain metastasesCancer, 2010
- The Dicey Role of Dicer: Implications for RNAi TherapyCancer Research, 2010
- MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growthCell Research, 2008
- Binding of eukaryotic initiation factor 3 to ribosomal 40S subunits and its role in ribosomal dissociation and anti-associationRNA, 2005
- Allogenic antibody-mediated identification of head and neck cancer antigensBiochemical and Biophysical Research Communications, 2004
- Role of angiogenesis in tumor growth and metastasisSeminars in Oncology, 2002
- Unified nomenclature for the subunits of eukaryotic initiation factor 311This letter arises from the Cold Spring Harbor Translational Control meeting held on September 6–10 2000 in Cold Spring Harbor, NY, USA.Trends in Biochemical Sciences, 2001
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000